Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in brca2 mutation carriers with prostate cancer and correlates with poor prognosis

European Urology

Volumn 67, Issue 3, 2015, Pages 496-503

  Risbridger, Gail P ^a   Taylor, Renea A ^a   Clouston, David ^b   Sliwinski, Ania ^c   Thorne, Heather ^c   Hunter, Sally ^c   Li, Jason ^c   Mitchell, Gillian ^c   Murphy, Declan ^c,d   Frydenberg, Mark ^a   Pook, David ^a   Pedersen, John ^a,b   Toivanen, Roxanne ^a   Wang, Hong ^a   Papargiris, Melissa ^a   Lawrence, Mitchell G ^a   Bolton, Damien M ^c  

^a MONASH UNIVERSITY   (Australia)

^b Tissupath Pty Ltd   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d EPWORTH HEALTHCARE   (Australia)

Author keywords

BRCA2 germline mutations; Familial prostate cancer; Intraductal carcinoma; Pathology; Patient derived xenografts

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; GENE DOSAGE; GERMLINE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; INTRADUCTAL CARCINOMA OF THE PROSTATE; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT;

EID: 84963948839     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.08.007     Document Type: Article

References (30)

1. Breast Cancer Linkage Consortium Cancer risks in BRCA2 mutation carriers J Natl Cancer Inst 91 1999 1310 1316
2. R. Wooster, G. Bignell, and J. Lancaster Identification of the breast cancer susceptibility gene BRCA2 Nature 378 1995 789 792
3. A. Liede, B.Y. Karlan, and S.A. Narod Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature J Clin Oncol 22 2004 735 742
4. J.P. Struewing, P. Hartge, and S. Wacholder The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews N Engl J Med 336 1997 1401 1408
5. D.F. Easton, L. Steele, and P. Fields Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13 Am J Hum Genet 61 1997 120 128
6. H. Thorne, A.J. Willems, and E. Niedermayr Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families Cancer Prev Res 4 2011 1002 1010
7. S. Sigurdsson, S. Thorlacius, and J. Tomasson BRCA2 mutation in Icelandic prostate cancer patients J Mol Med 75 1997 758 761
8. S.A. Narod, S. Neuhausen, and G. Vichodez Rapid progression of prostate cancer in men with a BRCA2 mutation Br J Cancer 99 2008 371 374
9. D.J. Gallagher, M.M. Gaudet, and P. Pal Germline BRCA mutations denote a clinicopathologic subset of prostate cancer Clin Cancer Res 16 2010 2115 2121
10. S.M. Edwards, D.G. Evans, and Q. Hope Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis Br J Cancer 103 2010 918 924
11. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974
12. S.A. Boorjian, R.J. Karnes, L.J. Rangel, E.J. Bergstralh, and M.L. Blute Mayo Clinic validation of the D'Amico risk group classification for predicting survival following radical prostatectomy J Urol 179 2008 1354 1360 discussion 1360-1
13. Bolton D, Cheng Y, Willems-Jones A, et al. Altered significance of D'Amico grading in prostate cancer patients linked to familial breast cancer (kConFab) cohort. Br J Urol Int. In press. http://dx.doi.org/10.1111/bju.12792
14. K. Kimura, T. Tsuzuki, and M. Kato Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens Prostate 74 2014 680 687
15. J.E. McNeal, and C.E. Yemoto Spread of adenocarcinoma within prostatic ducts and acini: morphologic and clinical correlations Am J Surg Pathol 20 1996 802 814
16. R.H. Osborne, J.L. Hopper, J.A. Kirk, G. Chenevix-Trench, H.J. Thorne, and J.F. Sambrook kConFab: a research resource of Australasian breast cancer families. Kathleen Cuningham Foundation Consortium for Research Into Familial Breast Cancer Med J Austr 172 2000 463 464
17. R. Toivanen, D.M. Berman, and H. Wang Brief report: a bioassay to identify primary human prostate cancer repopulating cells Stem Cells 29 2011 1310 1314
18. R. Toivanen, M. Frydenberg, and D. Murphy A preclinical xenograft model identifies castration-tolerant cancer-repopulating cells in localized prostate tumors Sci Transl Med 5 2013 187ra71
19. M.G. Lawrence, R.A. Taylor, and R. Toivanen A preclinical xenograft model of prostate cancer using human tumors Nat Protoc 8 2013 836 848
20. R.J. Cohen, J.E. McNeal, and T. Baillie Patterns of differentiation and proliferation in intraductal carcinoma of the prostate: significance for cancer progression Prostate 43 2000 11 19
21. C.C. Guo, and J.I. Epstein Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance Mod Pathol 19 2006 1528 1535
22. R. Montironi, M. Scarpelli, L. Cheng, A. Lopez-Beltran, M. Zhou, and F. Montorsi Do not misinterpret intraductal carcinoma of the prostate as high-grade prostatic intraepithelial neoplasia! Eur Urol 62 2012 518 522
23. L. Wu, N. Patten, C.T. Yamashiro, and B. Chui Extraction and amplification of DNA from formalin-fixed, paraffin-embedded tissues Appl Immunohistochem Mol Morphol 10 2002 269 274
24. L.H. Sobin, M. Gosporadowicz, and C. Wittekind TNM classification of malignant tumours 2009 Wiley-Blackwell Hoboken, NJ
25. H. Bonkhoff, T.M. Wheeler, T.H. van der Kwast, C. Magi-Galluzzi, R. Montironi, and R.J. Cohen Intraductal carcinoma of the prostate: precursor or aggressive phenotype of prostate cancer? Prostate 73 2013 442 448
26. R.J. Cohen, W.C. Chan, and S.G. Edgar Prediction of pathological stage and clinical outcome in prostate cancer: an improved pre-operative model incorporating biopsy-determined intraductal carcinoma Br J Urol 81 1998 413 418
27. R.J. Cohen, B.A. O'Brien, and T.M. Wheeler Ductal adenocarcinoma of the prostate Hum Pathol 42 2011 605 606 author reply 606-7
28. J.E. McNeal, J.H. Reese, E.A. Redwine, F.S. Freiha, and T.A. Stamey Cribriform adenocarcinoma of the prostate Cancer 58 1986 1714 1719
29. M.A. Rubin, A. de La Taille, E. Bagiella, C.A. Olsson, and K.M. O'Toole Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications Am J Surg Pathol 22 1998 840 848
30. K. Watts, J. Li, C. Magi-Galluzzi, and M. Zhou Incidence and clinicopathological characteristics of intraductal carcinoma detected in prostate biopsies: a prospective cohort study Histopathology 63 2013 574 579